Skip to main content
PharmGen Science, Inc. logo

PharmGen Science, Inc. — Investor Relations & Filings

Ticker · 004720 ISIN · KR7004720009 KO Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2026-03-12 Proxy Solicitation & In…
Country KR South Korea
Listing KO 004720

About PharmGen Science, Inc.

http://www.pharmgenscience.com/en/

PharmGen Science, Inc. is a pharmaceutical company engaged in the research, development, production, and sale of medicaments. The company's portfolio encompasses a range of prescription (ETC) and over-the-counter (OTC) drugs, including analgesics, antibiotics, and anti-inflammatory agents. A key strategic focus for the company is the discovery and development of novel drugs for gastrointestinal (GI) disorders. PharmGen Science aims to provide integrated pharmaceutical solutions by leveraging its diverse infrastructure and global network.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for PharmGen Science. It outlines the date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and details regarding the board's resolution. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2026-03-12 Korean
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price for convertible bonds (CB) due to a decline in the company's stock price. This type of filing, which details changes to capital structure instruments like convertible bonds, falls under the 'Capital/Financing Update' category as it directly relates to the company's financing activities and capital structure adjustments.
2026-03-11 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (PharmGen Science) regarding a significant change in financial results (30% or more change in revenue or profit structure). This is a standard disclosure requirement in the Korean stock market (KRX) for preliminary financial results before the final audit report is filed. Since it provides specific financial figures and explains the reasons for the change (impairment losses), it functions as an Earnings Release (ER) rather than a mere announcement of a report (RPA).
2026-02-09 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding the change of the representative reporter and major shareholders. This type of filing is classified as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-12-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service and Korea Exchange. This type of filing is a standard regulatory requirement for directors and major shareholders to disclose changes in their shareholdings, which falls under the 'Director's Dealing' category (DIRS) in the provided classification schema.
2025-12-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their personal shareholdings and transactions, which corresponds to the 'Director's Dealing' (DIRS) category in the provided schema.
2025-12-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.